Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $76.9300 (2.55%) ($76.9300 - $76.9300) on Fri. Mar. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.45% (three month average) | RSI | 66 | Latest Price | $76.9300(2.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.5% a day on average for past five trading days. | Weekly Trend | LGND advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(51%) IWN(51%) IWC(50%) IWO(50%) XBI(49%) | Factors Impacting LGND price | LGND will decline at least -1.225% in a week (0% probabilities). VIXM(-23%) SHY(-23%) GLD(-14%) BNDX(-14%) BND(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.225% (StdDev 2.45%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $74.14(3.76%) | 10 Day Moving Average | $73.85(4.17%) | 20 Day Moving Average | $72.67(5.86%) | To recent high | 0% | To recent low | 24.1% | Market Cap | $1.236b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |